The 2025 American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibition is set for December 7 through December 10 in Las Vegas, Nevada. The four-day conference is set to welcome more than 20,000 attendees as the society celebrates 60 years of annual Midyear Clinical Meeting & Exhibitions.
Registration for the 2025 ASHP annual conference is now open to members and non-members, with different price tiers for residents, pharmacy technicians, students, and more.
Today, we have a conference preview of kidney-related sessions and posters scheduled during the 2025 ASHP Midyear Clinical Meeting & Exhibition. The times and dates are accurate as of November 6, 2025. Consult the full schedule on the conference’s website for the most up-to-date information.
2025 ASHP Sessions on Nephrology Topics
Walking the Walk to Slow the Chronic Kidney Disease (CKD) Roll: Implementing Comprehensive Medication Management Pharmacy Services into CKD Care
- Tuesday, December 9, 10:00 AM – 11:00 AM
- Description: This session will focus on analyzing the medical burden for patients with chronic kidney disease and the opportunities for pharmacists to optimize their medication management. Attendees will learn how a learning and action collaborative can help a practice incorporate a pharmacist into the care team for patients with chronic kidney disease.
High Stakes in Cardiovascular Kidney Metabolic Syndromes: Betting on Evidence-Based Therapies
- Tuesday, December 9, 2:00 PM – 3:00 PM
- Description: Attendees will analyze the pathophysiological role of metabolic abnormalities and their implications for cardiovascular kidney metabolic (CKM) syndrome management, design comprehensive care plans for CKM syndrome patients by integrating current literature and evidence-based therapies, and develop case-based strategies to optimize the use of SGLT2 inhibitors, GLP-1 receptor agonists, finerenone, and RAAS inhibitors in clinical practice for CKM syndrome patients.
Protecting the Kidneys: Optimizing Medication Management for Better Acute Kidney Injury Outcomes
- Wednesday, December 10, 2:00 PM – 3:15 PM
- Description: In this session, speakers will describe nephrotoxic potential and burden. Attendees will be presented a scenario and will assess strategies to prevent hospital-acquired acute kidney injury. Then attendees will be presented a case and recommended the objectives and outcomes of nephrotoxin stewardship programs.
2025 ASHP Conference Posters on Nephrology Topics
The following posters are all set to be presented during the Professional & Fellows Posters presentation event. Consult the official schedule for the most up-to-date times and any last minute adjustments.
- Characterization of Intravenous Rituximab Pharmacokinetics in a Population Affected by Glomerular Kidney Diseases, a Clinical Trial
- Tuesday, December 9, 2:00 PM – 3:30 PM
- Clinical Trial for the Evaluation of the Influence of Rituximab Exposure on Clinical Outcomes in Glomerular Kidney Disease
- Tuesday, December 9, 2:00 PM – 3:30 PM
- Impact of Rituximab on Lymphocyte Subsets in Glomerulopathy-Affected Populations
- Tuesday, December 9, 2:00 PM – 3:30 PM
- Comparative Risk of Liver and Kidney Outcomes with GLP-1 Receptor Agonists versus DPP-4 Inhibitors in Patients with MASLD and Type 2 Diabetes
- Tuesday, December 9, 2:00 PM – 3:30 PM
- Implementation of an Updated Estimated Glomerular Filtration Rate Calculation for Inpatient Hospital Pharmacy Services: A Descriptive Quality Improvement Initiative
- Tuesday, December 9, 2:00 PM – 3:30 PM
Sign up for alerts and stay informed on the latest clinical guidelines and guideline updates.
Copyright © 2025 Guideline Central, all rights reserved.